Lutetium-177 dotatate

Lutetium-177 dotatate is a targeted treatment for certain types of neuroendocrine tumors, which are rare cancers that can occur in organs like the pancreas and intestines. It combines a radioactive isotope, lutetium-177, with a molecule that binds specifically to tumor cells. When injected into the body, it delivers focused radiation directly to the cancer cells, helping to shrink tumors and slow their growth while minimizing damage to surrounding healthy tissues. This innovative approach is part of a growing field of targeted therapies that enhance cancer treatment effectiveness.